Unique Challenges in Pulmonary Embolism Care for Special Populations
Clinics in Chest Medicine · 2026-12 · 47 (4) · 783-794
DOI: 10.1016/j.ccm.2026.07.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2026-12. Verfasst von Cosette Champion und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University, Durham, NC, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Major society guidelines highlight algorithms for the diagnosis, risk stratification, and management of pulmonary embolism to ensure standardized and evidence-based care. However, there are several populations in whom the clinical prediction rules are less applicable or less well validated who warrant additional consideration, including pregnant patients, patients with renal failure, patients with cancer, and elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Duke University, Durham, NC, USA.
- Department of Hematology, Washington University in St. Louis, St. Louis, MO, USA.
- Pulmonary and Critical Care Medicine Division, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: naydeno@wustl.edu.
Zitieren
APA
Champion, C., Sanfilippo, K., & Naydenov, S. (2026). Unique Challenges in Pulmonary Embolism Care for Special Populations. Clinics in Chest Medicine, 47(4), 783-794. https://doi.org/10.1016/j.ccm.2026.07.010
Vancouver
Champion C, Sanfilippo K, Naydenov S. Unique Challenges in Pulmonary Embolism Care for Special Populations. Clinics in Chest Medicine. 2026;47(4):783-794. doi:10.1016/j.ccm.2026.07.010
BibTeX
@article{Champion2026,
author = {Champion, Cosette and Sanfilippo, Kristen and Naydenov, Soophia},
title = {Unique Challenges in Pulmonary Embolism Care for Special Populations},
journal = {Clinics in Chest Medicine},
year = {2026},
volume = {47},
number = {4},
pages = {783--794},
doi = {10.1016/j.ccm.2026.07.010}
}
EUVIMED